A Study on Effect of Probiotic Inersan and Doxycycline in Treating Gum Disease
Phase 3
- Conditions
- Health Condition 1: null- Patients with Chronic Periodontitis
- Registration Number
- CTRI/2014/11/005215
- Lead Sponsor
- Sree Mookambika Institute of Dental Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
AAP International Workshop for Classification of Periodontal Diseases,1999.
-Subjects of both sexes
-Patients in the age group of 25-60 years
-Subjects with mild to moderate chronic periodontitis, as defined by probing pocket depths >=5mm in > 30 % of the probing sites.
-Subjects in good general health
Exclusion Criteria
-Antibiotic therapy in the past 2 months
- Allergic to doxycycline or probiotics.
-Subjects with diabetic mellitus,hypertension and psychiatric disorders
-Subjects who are pregnant/ lactating
-Smokers and/or alcoholics.
-Those undergone any periodontal therapy within last 6 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method oad of Lacto bacillus will be increased in Probiotic InersanTimepoint: One Month
- Secondary Outcome Measures
Name Time Method Improvement in clinical outcome and decrease in P. gingivalis count in all three groupsTimepoint: One month